Products injury firm Hissey Kientz LLP recently issued a press release that addresses reported adverse effects of Reglan (metoclopramide). The firm undertook an analysis of data in the FDA’s Adverse Event Reporting System related to the stomach disorder drug, and “identified at least 106 cases of tardive dyskinesia or other movement disorders reported among users of Reglan or its generic version, metoclopramide.”
Visit the Hissey Kientz website for more news on Reglan and its side effects, including causes and symptoms of tardive dyskinesia.
No Comments yet!